Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
ATP-sensitive potassium channelopathies: focus on insulin secretion
Frances M. Ashcroft
Frances M. Ashcroft
View: Text | PDF
Review Series

ATP-sensitive potassium channelopathies: focus on insulin secretion

  • Text
  • PDF
Abstract

ATP-sensitive potassium (KATP) channels, so named because they are inhibited by intracellular ATP, play key physiological roles in many tissues. In pancreatic β cells, these channels regulate glucose-dependent insulin secretion and serve as the target for sulfonylurea drugs used to treat type 2 diabetes. This review focuses on insulin secretory disorders, such as congenital hyperinsulinemia and neonatal diabetes, that result from mutations in KATP channel genes. It also considers the extent to which defective regulation of KATP channel activity contributes to the etiology of type 2 diabetes.

Authors

Frances M. Ashcroft

×

Figure 4

Options: View larger image (or click on image) Download as PowerPoint
PNDM mutations reduce channel inhibition by ATP. (A) Schematic of the mi...
PNDM mutations reduce channel inhibition by ATP. (A) Schematic of the mixture of channels with different subunit compositions expected when WT and mutant Kir6.2 are coexpressed (as in the heterozygous state). The relative numbers of the channel types expected if WT and mutant subunits segregate independently (i.e., follow a binomial distribution) are indicated above the figure. The circle indicates the only channel type predicted to show a substantial change in ATP sensitivity if the mutation affects ATP binding (see text). (B) Mean relationship between [ATP] and KATP current (G), expressed relative to the conductance in the absence of nucleotide (GC) for Kir6.2/SUR1 (red, n = 6) and heterozygous (black, n = 6) and homomeric (blue, n = 6) Kir6.2-R201H/SUR1 channels. The smooth curves are the best fit to the Hill equation. The IC50 was 7 μM, 12 μM, and 300 μM for WT, heterozygous R201H, and homomeric R201H channels, respectively. Data were obtained in the absence of Mg2+. Part B reproduced with permission from Proceedings of the National Academy of Sciences of the United States of America (83). (C) Mean relationship between [MgATP] and KATP current, expressed relative to the conductance in the absence of nucleotide for Kir6.2/SUR1 (red, n = 6) and heterozygous Kir6.2-R201H (black, n = 5) and heterozygous Kir6.2-I296L/SUR1 (blue, n = 5) channels. The smooth curves are the best fit to the Hill equation. The IC50 was 13 μM, 140 μM, and 50 μM for WT, heterozygous R201H, and heterozygous I296L channels, respectively. Data in C are from refs. 33 and 84.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts